Home / Business and Economy / UK Rap Icon Blade Brown Invests in Medical Cannabis
UK Rap Icon Blade Brown Invests in Medical Cannabis
26 Oct
Summary
- Blade Brown becomes an investor and partner in UK medical cannabis company Mamedica.
- Mamedica reported annualised sales of £21.5 million in 2025.
- The company's patient base surpassed 15,000 in 2025.

UK rap artist Blade Brown has become an investor and partner with Mamedica, a company operating within the regulated medical cannabis sector. This venture marks a significant expansion for Brown beyond his established music and entrepreneurial career.
Brown expressed his long-standing interest in the UK medical cannabis market since its legalization in 2018. He identified Mamedica's vision and growth potential as key factors in his decision to invest. He aims to increase awareness of available medical cannabis treatments in the UK.
Mamedica has experienced substantial growth, securing £4.5 million in funding in September 2025. By the end of 2025, the company reported annualised sales of £21.5 million and a patient base exceeding 15,000.
CEO Jon Robson highlighted Brown's understanding of both cannabis culture and its regulated future. He stated that Brown's partnership is crucial for Mamedica's continued expansion and its mission to improve access to specialist treatments across the UK.